Blood Cancer Discov. 2023 Sep 1;4(5):342-345. doi: 10.1158/2643-3230.BCD-ND2023-0003.
The 17th International Conference on Malignant Lymphoma (ICML) took place in Lugano, Switzerland, from June 13-17 this year. The conference has been held every 2 to 3 years since its inception in 1981 and has become a significant and influential gathering for lymphoma researchers from around the world, this year hosting 4,761 registered attendees. Here, we provide some highlights of what we felt were the most noteworthy findings, both clinical and pre-clinical, across various lymphoma entities, presented at the 17th ICML.
第 17 届国际恶性淋巴瘤会议(ICML)于今年 6 月 13 日至 17 日在瑞士卢加诺举行。自 1981 年成立以来,该会议每 2 至 3 年举办一次,已成为来自世界各地的淋巴瘤研究人员的一个重要且有影响力的聚会,今年有 4761 名注册参会者。在这里,我们提供了一些我们认为在第 17 届 ICML 上展示的各种淋巴瘤实体中最值得注意的临床和临床前发现的亮点。